| Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy PL Anderson, AY Liu, JR Castillo-Mancilla, EM Gardner, SM Seifert, ... Antimicrobial agents and chemotherapy 62 (1), 10.1128/aac. 01710-17, 2018 | 230 | 2018 |
| A human thrifty phenotype associated with less weight loss during caloric restriction M Reinhardt, MS Thearle, M Ibrahim, MG Hohenadel, C Bogardus, ... Diabetes 64 (8), 2859-2867, 2015 | 107 | 2015 |
| The solvent-free and catalyst-free conversion of an aziridine to an oxazolidinone using only carbon dioxide TG Nathaniel Green Chemistry 13 (11), 3224-3229, 2011 | 97 | 2011 |
| Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in sub … L Stranix-Chibanda, PL Anderson, D Kacanek, S Hosek, S Huang, ... Clinical Infectious Diseases 73 (7), e1893-e1900, 2021 | 42 | 2021 |
| Perceived stress and anhedonia predict short-and long-term weight change, respectively, in healthy adults M Ibrahim, MS Thearle, J Krakoff, ME Gluck Eating behaviors 21, 214-219, 2016 | 35 | 2016 |
| Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following tenofovir alafenamide: the TAF-DBS study J Yager, J Castillo-Mancilla, ME Ibrahim, KM Brooks, C McHugh, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 84 (3), 323-330, 2020 | 33 | 2020 |
| High Fat and Sugar Consumption During Ad Libitum Intake Predicts Weight Gain EJ Stinson, P Piaggi, M Ibrahim, C Venti, J Krakoff, SB Votruba Obesity 26 (4), 689-695, 2018 | 27 | 2018 |
| Approaches to handling missing or “problematic” pharmacology data: Pharmacokinetics DJ Irby, ME Ibrahim, AM Dauki, MA Badawi, SM Illamola, M Chen, ... CPT: pharmacometrics & systems pharmacology 10 (4), 291-308, 2021 | 24 | 2021 |
| Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patients ME Ibrahim, C Chang, Y Hu, SL Hogan, N Mercke, M Gomez, CL O’Bryant, ... European journal of clinical pharmacology 75, 51-57, 2019 | 22 | 2019 |
| Bioequivalence of tenofovir and emtricitabine after coencapsulation with the proteus ingestible sensor ME Ibrahim, KM Brooks, JR Castillo-Mancilla, C McHugh, M Morrow, ... AIDS Research and Human Retroviruses 34 (10), 835-837, 2018 | 15 | 2018 |
| Individualized adherence benchmarks for HIV pre-exposure prophylaxis ME Ibrahim, JR Castillo-Mancilla, J Yager, KM Brooks, L Bushman, ... AIDS Research and Human Retroviruses 37 (6), 421-428, 2021 | 12 | 2021 |
| Energy Expenditure and Hormone Responses in Humans After Overeating High‐Fructose Corn Syrup Versus Whole‐Wheat Foods M Ibrahim, S Bonfiglio, M Schlögl, KL Vinales, P Piaggi, C Venti, M Walter, ... Obesity 26 (1), 141-149, 2018 | 12 | 2018 |
| Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarate KM Brooks, ME Ibrahim, JR Castillo-Mancilla, S MaWhinney, K Alexander, ... Journal of Antimicrobial Chemotherapy, 2019 | 11 | 2019 |
| Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium and high adherence to emtricitabine/tenofovir alafenamide vs. emtricitabine/tenofovir disoproxil … JL Yager, KM Brooks, JR Castillo-Mancilla, C Nemkov, M Morrow, ... AIDS 35 (15), 2481-2487, 2021 | 10 | 2021 |
| Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir KM Brooks, JR Castillo-Mancilla, M Morrow, S MaWhinney, J Blum, ... Journal of Antimicrobial Chemotherapy 75 (11), 3303-3310, 2020 | 10 | 2020 |
| Tenofovir diphosphate in dried blood spots following escalating TAF/FTC dosing J Yager, JR Castillo-Mancilla, ME Ibrahim, C McHugh, S MaWhinney, ... | 6 | 2019 |
| IMPAACT 2009 team. Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed preexposure … L Stranix-Chibanda, PL Anderson, D Kacanek, S Hosek, S Huang, ... Clin Infect Dis, 2020 | 5 | 2020 |
| revisiting the pharmacological forgiveness of HIV Pre-exposure prophylaxis ME Ibrahim, DV Glidden, RM Grant, PL Anderson AIDS Research and Human Retroviruses 37 (6), 407, 2021 | 2 | 2021 |
| An evaluation of a novel nanoformulation of imatinib mesylate in a mouse model of lupus nephritis U Fogueri, G Charkoftaki, G Roda, S Tuey, M Ibrahim, I Persaud, ... Drug Delivery and Translational Research, 1-10, 2022 | 1 | 2022 |
| A comparison of covariate selection techniques applied to pre-exposure prophylaxis (PrEP) drug concentration data in men and transgender women at risk for HIV S Peterson, M Ibrahim, PL Anderson, CM Moore, S MaWhinney Journal of Pharmacokinetics and Pharmacodynamics 48 (5), 655-669, 2021 | 1 | 2021 |
